Background: Calpain-10 is a ubiquitously expressed protease that serves as an intracellular calcium-dependent cysteine protease and is regarded to be one of the candidate genes for type 2 diabetes mellitus (T2DM). We aimed to identify the association of the common variants of this gene and the risk of T2DM in the Kurdish ethnic group of Iran. Methods: Study groups included 173 T2DM and 173 normoglycemic subjects. Genotyping was determined by PCR-RFLP. Genotypic and allelic frequencies were then evaluated. Data was analyzed using SPSS software. 
INTRODUCTION
Diabetes mellitus is one of the most common metabolic diseases and a health-care challenge of the twenty-first century [1] . Globally, as of 2010, it is estimated that there are 285 million diabetic people with type 2 making up about 90% of the cases [2] . Its incidence is rising rapidly, and it is estimated that by 2030 this number will almost double [3] . Substantial evidence has been presented that type 2 diabetes mellitus (T2DM) drives from the coexistence of genetic and environmental factors [4, 5] ; however, the molecular mechanisms underlying T2DM are poorly understood. In recent years, genome-wide association studies have identified several candidate genes contributing to T2DM predisposition. The calpain-10 gene (CAPN10), a ubiquitously expressed protease that serves as an intracellular calcium-dependent cysteine protease, is regarded to be one of the candidate genes for T2DM [6] [7] [8] [9] [10] [11] . Genetic and functional data have suggested that calpain-10 has an important role in insulin resistance and intermediate phenotypes. There is emerging evidence of a role for calpain-10 in glucose transporter 4 translocation and insulin secretion [12] . Several single nucleotide polymorphisms (SNP) of CAPN10 are known to increase the risk of type 2 diabetes in many populations. These SNPs include: SNP-43 (an A/G transition within intron-3), SNP-19 (two or three repeats of a 32 bp sequence within intron-6), and SNP-63 (a C/T transition within intron-13) [13] [14] [15] [16] . However, despite the body of evidence supporting the functionality of CAPN10 polymorphisms, the negative associations between these variants and T2DM have also been reported in several populations, including Britains [17] , Samoans [18] , native Canadians [19] , Finns [20] , and Japanese [21] . To our knowledge, because these relationships have not been reported in the Kurdish ethnic group so far and controversial results in other populations, this study was aimed to explore the possible association between the CAPN10 variants and T2DM and its metabolic quantitative traits in a sample of an Iranian Kurdish ethnic group.
MATERIALS AND METHODS

Subjects and protocols
The studied population included 173 (males/females: 82/91; age: 54.97 ± 11.01 years) Iranian, unrelated patients with type 2 diabetes and 173 (males/females: 73/ 100; age: 50.29 ± 9.64 years) Iranian, unrelated healthy controls. All subjects originated from the Ilam and Kermanshah provinces situated in the west of Iran and belonged to the Kurdish ethnic group. Diabetic and healthy controls were distinguished based on their glycemic status, which was defined according to WHO 1997 criteria [22] . The control group contained only individuals with a normal fasting glucose level and negative family history of type 2 diabetes among first-degree relatives. The written informed consent was obtained from all participants before enrollment in the study. Screening included standardized questionnaires on personal data and clinical measurements such as age, gender, obesity, drug consumption during the past month, and medical or family history of diabetes [23] . All those who were not taking diabetes medication underwent a 2 hour oral glucose tolerance test (OGTT) after an overnight fast. Criteria for control selection were fasting glucose < 6.1 mmol/L and 2 hour plasma glucose < 7.8 mmol/L after OGTT. Diabetes was defined as fasting glucose ≥ 7.0 mmol/L, 2 hour glucose ≥ 11.1 mmol/L after OGTT, or use of hypoglycemic medication. Systolic and diastolic blood pressure was measured twice in the right arm of the subjects who had been resting for at least 10 minutes in a comfortable position. Signed informed consent was obtained from all subjects, and the study was approved by the Institutional Ethics Committee. All participants were interviewed to obtain clinical data and type 2 diabetes mellitus family history. BMI was estimated through dividing weight in kilograms by the height in meters squared. Insulin resistance was assessed from glucose and insulin concentrations using homeostasis model assessment of insulin resistance (HOMA-IR) equation [24] .
Sample preparation
Blood samples were collected from patients and controls in the morning, after an overnight (12 -14 hours) fasting. 5 mL of venous blood were withdrawn from the antecubital vein into Vacutainer tubes containing EDTA as the anticoagulant. To separate plasma, blood samples were centrifuged at 3000 rpm for 10 minutes. Supernatant was used for biochemical experiments, and the buffy coat and red blood cell pellet were used for DNA extraction.
Biochemical assays
Serum blood glucose, triglycerides, total cholesterol, LDL-C and HDL-C levels were measured by the standard enzymatic method (Pars Azmon kit, Iran), using the auto analyzer system BT3000 (Biotechnica, Italy). Serum concentrations of insulin were assessed using an ELISA kit specific for human insulin according to the manufacturer's instructions (Monobind Inc., USA).
Genotyping
Leukocyte genomic DNA was extracted from the blood specimen using the standard procedure involving proteinase K and phenol/chloroform. The CAPN10 SNP-43 polymorphic site (A/G) was amplified by the polymerase chain reaction (PCR) method using the primer pair 5´-ACGCTTGCTGTGAAGTAATG-C-3´
(forward) and 5´-GCTGCCTCAATCCCACCTC-3´ (reverse). PCR was performed in a final volume of 25 µL containing 100 ng genomic DNA, 1.5 mmol/L MgCl 2 , 0.5 mmol/L of each dNTPs, and 0.5 pmol of each primer. After an initial denaturation of 2 minutes at 94ºC, the samples were subjected to 30 cycles at 94ºC for 1 minute, 61ºC for 40 seconds, and 72ºC. for 30 seconds, with a final extension of 10 minutes at 72ºC. The 102 bp product was digested with HpyCH4V for 2 hours at 37ºC followed by agarose gel electrophoresis. The di- gested products were stained with ethidium bromide. Gallele was not cleaved by HpyCH4V and gave a 102 bp band and A-allele was cleaved into two bands 82 and 20 bp. A fragment containing SNP-19, an insertion/deletion polymorphism consisting of two or three repeats of a 32 bp sequence, was amplified using the primer pair 5´-CAGTTTGGTTCTCTTCAGCG-3´ (forward) and a reverse primer of 5´-GCAGGGTCTAAGCAGCAGC-3´ (reverse). PCR conditions were the same as for SNP-43, except the annealing temperature was 59ºC. The PCR product was electrophoresed on polyacrylamide gel and stained with ethidium bromide. The two 32 bp repeats (2R) and three 32 bp repeats (3R) were visualized as 146 bp and 178 bp bands, respectively, on agarose gel. The CAPN10 SNP-63 polymorphic site (C/T) was amplified by the polymerase chain reaction (PCR) method using the primer pair 5´-GCCTGACGGGGGTGCAG-3´ (forward) and 5´-CAGTGCGTGGTG-CCTGAAG-3´ (reverse). PCR conditions were the same as for SNP-43, except the annealing temperature was 63ºC. The PCR product was digested with the restriction enzyme BtsI at 37ºC for 2 hours followed by agarose gel electrophoresis. The C-allele was not cleaved by BtsI and gave a 99 bp band and the T-allele was cleaved into two bonds 78 and 21 bp.
Statistical analysis
All statistical analyses were carried out using the statistical program SPSS (version 19, SPSS, Chicago, IL, USA); Differences in genotype/allele frequencies were compared by the Chi-square test or Fisher exact test where appropriate. One-way analysis of variance (ANOVA) was utilized to compare the clinical features among groups with different genotypes. Odds ratios (ORs) and 95% CI were calculated by logistic regression analysis using diabetes as a dependent variable and the genotypes as independent variables. We used the Pearson's goodness-of-fit chi-square (χ 2 ) test to evaluate deviation from Hardy-Weinberg equilibrium. Armitage's trend test was applied to assess for the presence of association between different groups of genotypes. Other genetic models including dominant, recessive and multiplicative models were also considered in the analysis of SNP association [25] . Baseline quantitative results were expressed as mean ± standard deviation (SD) and compared with Student's ttest; the continuous variables that failed the normality test were logarithmically transformed before analysis. The variables transformed were triglyceride, insulin, and HOMA-IR. Statistical differences are based on analyses of log-transformed data, but means of untransformed data are presented in tables.
RESULTS
The clinical, anthropometrical, and biochemical characteristics of the participants are shown in Table 1 . Gender distribution was almost the same in T2DM patients and their controls. The mean of age in T2DM patients and the control group was 54.98 ± 11.1 and 53.3 ± 9.7, respectively. All characteristics of the participants differed significantly between T2DM and normoglycemic controls (p < 0.05). T2DM subjects had significantly higher values for BMI, triglyceride, HbA1c, glucose, total cholesterol, waist to hip ratio, LDL-C, HOMA-IR, diastolic and systolic blood pressure, and insulin and lower levels of HDL-C than normoglycemic control subjects (p < 0.05).
The genotype distribution and relative allele frequencies of SNP-43, -19, and -63 polymorphisms at the CAPN10 gene in the study subjects are shown in Table 2 . All three variants were in Hardy-Weinberg equilibrium in T2DM (χ 2 = 1.88, df = 1, p = 0.17 for SNP-43; χ 2 = 0.49, df = 1, p = 0.48 for SNP-19; χ 2 = 2.76, df = 1, p = 0.10 for SNP-63) and control subjects (χ 2 = 2.78, df = 1, p = 0.096 for SNP-43; χ 2 = 2.26, df = 1, p = 0.13 for SNP-19; χ 2 = 3.23, df = 1, p = 0.07 for SNP-63). The allelic frequency of the A-allele of SNP-43 variant was significantly different (p = 0.01) between case and control groups (18% vs. 11%). The genotype frequencies for SNP-43 did not show any significant difference between case and control individuals. However, the dominant model of SNP-43 (GG vs. GA+AA) was found to be significantly associated with T2DM (OR = 1.75, 95% CI = 1.06 -2.89, p < 0.029). The distribution and allele frequency of other SNPs (SNP-19 and -63) did not show any significant difference between the study groups. We classified the anthropometrical, clinical, and biochemical characteristics of the study subjects according to the dominant model of SNP-43, -19, and -63 (Table  3 , 4, and 5, respectively). As shown in Table 3 , FSI (GG, 6.7 ± 2.32, vs. GA+AA, 7.49 ± 1.99 µIU/mL; p = 0.043) and HOMA-IR (GG, 1.55 ± 0.56, vs. GA+AA, 1.76 ± 0.48 mmol/L; p = 0.026) were higher in the control subjects with the GA+AA genotypes when compared with the GG genotypes. In T2DM subjects, there was no significant difference in any characteristics between the GG and GA+AA genotypes of SNP-43. Table 4 represents the characteristics of the study subjects categorized according to the dominant model for SNP-19. As shown in this table, normoglycemic subjects carrying the 2R/3R+3R/3R genotypes of SNP-19 had significantly lower levels of HDL-C (2R/2R, 3.03 ± 0.67, vs. 2R/3R+3R/3R, 2.67 ± 0.75 mmol/L; p = 0.034) as compared with those with the 2R/2R genotype. In T2DM subjects, no significant difference was found in any characteristics between 2R/2R and 2R/3R+3R/3R genotypes of SNP-19. Table 5 shows the characteristics of the study subjects categorized according to the dominant model of SNP-63. As shown in this table, T2DM subjects carrying the CT+TT genotypes of SNP-63 had significantly higher LDL-C (CC, 3.35 ± 0.92, vs. CT+TT, 3.89 ± 0.98 mmol/L; p = 0.015) as compared with those with the CC genotype. In normoglycemic subjects, no significant difference was found in any of the clinical or biochemical parameters between CC and CT+TT genotypes. None of the haplotype combinations of SNP-43, -19, and -63 suggested a significant raised risk for T2DM. Also, none of the anthropometrical, clinical, and biochemical characteristics was significantly different among these haplotypes (data not shown).
DISCUSSION
One commonly used approach to define the genetic predisposition of T2DM is the candidate gene approach. This approach focuses on the search for an association between T2DM and sequence variants in or near biologically defined candidate genes which have been chosen based on their known physiological function. The importance of these variants or other nearby variants is tested by comparing the frequency in T2DM patients and normal glucose tolerant subjects [26] . CAPN10 is a confirmed T2DM candidate gene. The contribution of CAPN10 variants to T2DM risk has been confirmed in some, but not all, populations studied so far [17] [18] [19] 21, [27] [28] [29] . These variations include: SNP-43, SNP-19, and SNP-63 [13] [14] [15] [16] . In this study, we examined the association of the SNP-43, -19, and -63 in the CAPN10 gene with type 2 diabetes mellitus and related metabolic traits using a case-control method. We selected these SNPs due to their previous association with T2DM. According to the results obtained from this study, neither genotypic frequencies nor the allelic frequencies of any of the SNP-19 and -63 were found to be associated with T2DM. This is in agreement with studies from the European Americans [15] , British [17] , OjiCree [19] , Southern Indians [30] , West Africans [31] , Samoan [18] , Danish/Swedish [29] , Japanese [21] , Finnish [20] , and Chinese [32] populations. A study in India also failed to find any association between these SNPs individually and T2DM, except for the minor allele of SNP-63 that was associated with impaired fasting plasma glucose/impaired glucose tolerance [14] . We found that the frequency of the minor allele of SNP-43 was significantly different between T2DM and control groups. Nevertheless, the genotypes of SNP-43 failed to show any significant association with the risk of T2DM, except for its dominant model. These findings are consistent with the results from previous studies [8, 30, 33, 34] . Compared with GA+AA genotypes, the GG genotype of SNP-43 was significantly associated with the lower levels of FSI and HOMA-IR in control subjects. This has been confirmed by previous studies [34, 35] . However, the opposite result were obtained in a study by Lynn et al. [13] . The reason for this controversy is unknown and differences in the genetic and/or environmental background as well as in recruitment procedures of the studied populations may have played a role. We also found that normoglycemic subjects carrying the 2R/3R+3R/3R genotypes of SNP-19 had significantly lower levels of HDL-C in comparison with the normal subjects carrying the 2R/2R genotype. To our knowledge, this finding is the first report of the association between 2R/3R+3R/3R genotypes of SNP-19 and lower levels of HDL-C. A Japanese study showed an association between the 3R/3R genotype of SNP-19 and higher BMI and HbA1c [36] . Another finding of our study was the association between CT+TT genotypes of SNP-63 and higher levels LDL-C. This association has not been reported so far. The reason for the apparent discrepancies between the studies, including ours, can be attributed to several factors such as the study design, sample size, population heterogeneity, and gene-environment interactions [37, 38] . In conclusion, this is the first study performed in the Kurdish ethnic group from West Iran, in which a signif-icance of genetic variation of the CAPN10 gene was investigated in the pathogenesis of T2DM. The findings of our study revealed that the GA+AA genotypes and the minor allele frequency of SNP-43 are significantly different between study groups and showed an increased risk for T2DM. In addition, the SNP-19 and -63 of CAPN10 gene are not associated with the risk of T2DM; however, they affect some metabolic traits in this population. Nevertheless, future investigations including larger cohorts of subjects, as well as studies in other populations, are needed to substantiate these findings.
